OpenCitations
metadata only
Bruton Tyrosine Kinase Represents A Promising Therapeutic Target For Treatment Of Chronic Lymphocytic Leukemia And Is Effectively Targeted By PCI-32765
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Bruton Tyrosine Kinase Inhibitor PCI-32765 Thwarts Chronic Lymphocytic Leukemia Cell Survival And Tissue Homing In Vitro And In Vivo#19605
- Bruton’s Tyrosine Kinase (BTK) As A Dual-Function Regulator Of Apoptosis#19597
- Bruton’s Tyrosine Kinase (Btk): Function, Regulation, And Transformation With Special Emphasis On The PH Domain#19618
- Phosphorylation Of Bruton's Tyrosine Kinase By c-Abl.#412846
- Bruton Tyrosine Kinase (BTK) And Its Role In B-cell Malignancy#19615
Record · ID 412861
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive